ArticleScientific reports2021

A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus.

S Kiruthika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.